Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
Sales of “Olainfarm” grew by 35% in January
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids Citi
Valoda EN
Statuss Publicēts
Versija
Datums 2012-02-15 16:01:55
Versijas komentārs
Teksts

 

Olaine, February 15, 2012

 

 

 

 Sales of “Olainfarm” grew by 35% in January

 

Preliminary data on consolidated sales of AS “Olainfarm” during January of 2012,

shows that sales have increased by 35% compared to the similar period one year

ago and have reached 3.52 million lats (5 million euros). Biggest sales increases were

achieved in Latvia (by 389%), Taiwan (by 259%), Ukraine (by 88%), and Russia (by 49%).

Major sales markets of AS “Olainfarm” during January were Russia, Ukraine, Latvia,

Belarus and the USA.

 

Consolidated sales, January 2012

 

Share in total sales

 

Increase to January 2011

 

Russia

 

38%

 

49%

 

Ukraine

 

28%

 

88%

 

Latvia

 

19%

 

389%

 

Belarus

 

5%

 

-51%

 

USA

 

3%

 

NA

 

Taiwan

 

1%

 

259%

 

Bulgaria

 

1%

 

-54%

 

Spain

 

1%

 

NA

 

Azerbaijan

 

1%

 

7%

 

Kyrgyzstan

 

1%

 

NA

 

Other

 

2%

 

-87%

 

Total

 

100%

 

35%

 

 

 

Sales made by pharmacies owned by AS “Olainfarm” in January 2012 were 0.52

million lats (0.74 million euro).

 

Thus, according to preliminary unconsolidated sales figures of AS “Olainfarm” for January of 2012,

unconsolidated sales made during January were 3.02 million lats (4.29 million euro), which represents

an increase by 16% compared to unconsolidated sales made in January 2011. Biggest sales

increases were achieved in Taiwan (by 259%), Ukraine (by 88%), Russia (by 49%), Latvia (by 25%).

According to unconsolidated sales, the major sales markets of AS “Olainfarm” in January 2012 were

Russia, Ukraine, Belarus, Latvia and the USA.

Unconsolidated sales in January 2012

 

Share in total sales

 

Increase to January 2011

 

Russia

 

44%

 

49%

 

Ukraine

 

33%

 

88%

 

Belarus

 

6%

 

-51%

 

Latvia

 

6%

 

25%

 

USA

 

4%

 

NA

 

Taiwan

 

2%

 

259%

 

Bulgaria

 

1%

 

-54%

 

Spain

 

1%

 

NA

 

Azerbaijan

 

1%

 

7%

 

Kyrgyzstan

 

1%

 

NA

 

Other

 

2%

 

-87%

 

Total

 

100%

 

16%

 

 

 

Although no forecasts of AS “Olainfarm” are formally approved, for planning purposes

the Board of the Company is using forecasts according to which the unconsolidated

sales of the company in 2012 will reach 40.6 million lats (57.8 million euro), which represents

an increase by 12% compared to sales made during 2011. According to these preliminary

unconsolidated sales figures, during January 2012, 7.4% of sales forecasts for the year 2012 are already met.

 

 

""""

 

 

AS Olainfarm is one of the biggest pharmaceutical companies in Latvia with nearly 40 years of experience in production of medication and chemical and pharmaceutical products.

A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being

exported to more than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.    

 

 

 

 

Information prepared by:

Salvis Lapins

 

Member of the Board

 

AS Olainfarm

 

Cell: +371 26448873

 

e-mail:

Salvis.Lapins@olainfarm.lv

 

 

 

 

 

 

 

 

 

Pielikumi